Could a higher dose of digestive enzymes better restore gut health after surgery?
NCT ID NCT07751367
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial asks whether a higher dose of an enzyme pill (Oryz-Aspergillus enzyme and pancreatin) can better ease digestive symptoms in adults who have had stomach or pancreas surgery. Participants will take either a high or low dose with meals for four weeks. The study tracks changes in digestive symptoms and nutritional status to see if the higher dose offers more benefit.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Oryz-Aspergillus enzyme and pancreatin tablet
- What this could lead to
- If successful, this could establish a standard, higher-dose enzyme treatment to improve digestion and nutrition after gastrointestinal surgery.
- What could go wrong
- The trial is relatively small and early, so results may not apply to everyone. Higher doses could also increase the risk of side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC EXOCRINE INSUFFICIENCY, ADUL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, 300000, China